Product Recalls: July 15, 2020 – August 12, 2020
Health Letter, September 2020
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
Auryxia (ferric citrate) tablets, 210 mg, 200 tablets per bottle. Manufactured for and distributed by: Keryx Biopharmaceuticals, Inc.
Carbamazepine tablets, 200 mg, 100-unit dose tablets per box. Repackaged by: RemedyRepack Inc.
Estriol capsule, 6 or 8 mg, 90 capsules per bottle. MasterPharm.
Finasteride Plus capsule, 1.25 mg, 90 capsules per bottle. MasterPharm.
Lisinopril tablets, 10 mg, 1,000 count bottles. Manufactured by: Lupin Limited. Manufactured for: BluePoint Laboratories.
Metformin hydrochloride extended-release tablets; 500, 750 or 1,000 mg; 10-, 60-, 90- or 500-count bottle. Manufactured for: Granules Pharmaceutical Inc. or Lupin Pharmaceuticals, Inc. Manufactured by: Granules India Limited or Lupin Limited.
Progesterone (modified-release) capsule; 50, 100, 150 or 200 mg; 30 or 90 capsules per bottle. MasterPharm.
Tadalafil capsule; 3, 7, 12, 18 or 26 mg; 90 capsules per bottle. MasterPharm.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.